ARCHIVES

DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year

This article is from The Cancer Letter archive.

Vol. 13 No. 09 | February 27, 1987

Download PDF Visit The Full Archive

Related Articles

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

NCI Trials Listed

June 25, 2010

NCI-Approved Clinical Trials

May 30, 2003

NCCS Networker Volume 3 Issue 4, Fall 1989

September 13, 1989

Cancer Education: NCI Offers Training In Epidemiology And Genetics

April 17, 1998

CHMP Delivers Positive Opinion For Two-Dose HPV Vaccine

February 28, 2014